Huntington Ingalls Industries
HII
$303.99
-4.08%
Huntington Ingalls Industries is the largest independent U.S. military shipbuilder, operating three segments: Ingalls Shipbuilding (non-nuclear surface combatants such as Arleigh Burke-class destroyers and amphibious assault ships), Newport News Shipbuilding (the sole builder of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines), and Mission Technologies (uncrewed vessels, IT, and government services). Spun out of Northrop Grumman in 2011, HII occupies a uniquely entrenched position in the U.S. defense industrial base, effectively operating as a duopoly partner with General Dynamics' Bath Iron Works and Electric Boat on the Navy's most strategically critical programs. The current investor debate centers on whether a structurally rising naval procurement cycle — including proposals for a 355-ship fleet and a $1.5 trillion Pentagon budget — can translate into durable margin expansion after a multi-year stretch of weak shipbuilding profitability and cost overruns. Sentiment has whipsawed: a strong Q3 2026 beat and raised guidance in late October drove a sharp single-day re-rating, yet the stock remains roughly flat over twelve months as investors weigh execution risk, labor and supply-chain constraints, and emerging competition from venture-backed disruptors like Anduril in submarine components and Saronic in robotic warships.…
HII
Huntington Ingalls Industries
$303.99
Related headlines
Investment Opinion: Should I buy HII Today?
Rating: Hold with a constructive bias. HII is a structurally entrenched naval duopolist whose Q3 2026 results finally validated the margin-recovery thesis — gross margin of 13.57%, operating income of $246 million, and 10.81% revenue growth — yet at $316.93 the stock already trades at 22.10x trailing earnings, in the upper-middle of its 9.41x-25.82x historical band, leaving only moderate upside to the $358.58 average analyst target (13.1%). The core thesis is that a forward PE of 15.48x on consensus EPS of $27.80 discounts roughly 30% earnings growth that is now visibly beginning to materialize, but the Street's 6 Buy / 6 Hold split with zero Sells reflects genuine uncertainty about whether the improvement is durable contract execution or favorable one-time adjustments.
Supporting evidence is mixed but tilts modestly positive. Revenue accelerated to 10.81% YoY ($3.537 billion vs. $3.192 billion), with sequential cadence of $3.099B, $3.418B, and $3.537B showing steady expansion, and the forward consensus of $16.64 billion implies continued mid-to-high single-digit growth. Profitability is improving sequentially — gross margin rose from 13.17% to 13.22% to 13.57% and operating income from $155M to $210M to $246M across Q1-Q3 2026 — but the 4.85% trailing net margin and 4.87% operating margin remain far below defense-prime norms, which structurally justifies part of the valuation discount. On valuation, the PS of 1.07x and EV/Sales of 1.11x sit well below the 2-3x typical of large-cap primes and at the very bottom of HII's own 2.46x-4.82x historical range, while TTM free cash flow of $524 million yields roughly 3.9% of the $13.36 billion market cap — but the PEG of 2.16 confirms no growth-adjusted bargain.
The biggest risks that could invalidate the thesis are (1) margin durability — a reversion toward the 11.57% Q4 2025 gross margin would collapse the forward-PE narrative, (2) cash-flow volatility, with quarterly FCF ranging from -$464 million to +$429 million, and (3) emerging disruptors like Anduril's $2.9 billion submarine-component contract and Saronic's robotic warship funding pressuring long-term pricing and awards. This Hold would upgrade to Buy if gross margin holds above 13.5% for two more quarters and the stock pulls back toward the $280-$290 zone (near the $281 analyst low target), or downgrade to Sell if gross margin slips below 12.5% or a fixed-price program charge emerges at Newport News. Net verdict: fairly valued to modestly undervalued on forward earnings, but not cheap on trailing or growth-adjusted metrics — a name to accumulate on weakness rather than chase after an 18% one-month rally.
Sign up to view all
HII 12-Month Price Forecast
HII presents a balanced risk/reward at $316.93: the forward PE of 15.48x is genuinely attractive if the company delivers the ~30% EPS growth consensus expects, and three quarters of sequential margin improvement plus 10.81% revenue growth provide real evidence the recovery is underway. However, the trailing PE of 22.10x sits in the upper-middle of the historical band, the PEG of 2.16 offers no growth-adjusted discount, and the 4.85% net margin leaves minimal buffer against fixed-price overruns. The stock's 18.02% one-month rally versus -1.99% for SPY has already captured much of the post-earnings re-rating, and the 6 Buy / 6 Hold split signals the Street wants proof before chasing. I would upgrade to bullish if gross margin holds above 13.5% for two more quarters and the stock consolidates toward $290, or downgrade to bearish if gross margin slips below 12.5% or a program charge emerges at Newport News.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Huntington Ingalls Industries's 12-month outlook, with a consensus price target around $362.58 and implied upside of +19.3% versus the current price.
Average Target
$362.58
12 analysts
Implied Upside
+19.3%
vs. current price
Analyst Count
12
covering this stock
Price Range
$281 - $406
Analyst target range
Coverage is solid with 12 analysts, and the distribution of 6 Buy, 6 Hold, and 0 Sell ratings yields a consensus recommendation of "buy" with a mean rating of 2.08 (where 1.0 is a strong buy and 3.0 a hold). The average target price of $358.58 implies roughly 13.1% upside from the current $316.93, a moderate rather than aggressive bullish signal that is consistent with a split house view — half the Street sees the margin recovery as durable, half wants proof. The consensus leans cautiously bullish, and the absence of any Sell ratings suggests the debate is about timing and magnitude of upside rather than downside risk.
The target range of $281.00 to $406.00 is wide — a spread of $125, or roughly 39% of the current price — which signals genuine disagreement about the earnings trajectory rather than mere calibration differences. The high target of $406 implies roughly 28% upside and would require multiple expansion toward the upper end of HII's historical PE band alongside successful execution on the naval backlog and continued margin improvement from the Q3 13.57% gross margin level; the low target of $281 sits about 11% below the current price and effectively prices in margin compression or program execution setbacks. Recent institutional activity shows stability rather than momentum — Citigroup and TD Cowen have reiterated Buy ratings through 2026, while Bernstein and Wells Fargo remain at Market Perform/Equal Weight — indicating the Street is holding its positions pending confirmation from coming quarters rather than chasing the post-earnings rally.
Bulls vs Bears: HII Investment Factors
The bull case rests on a genuine, data-confirmed inflection: three consecutive quarters of gross-margin expansion (13.17% to 13.57%), 10.81% revenue growth, and a forward PE of 15.48x that discounts roughly 30% EPS growth the company is now visibly beginning to deliver. The bear case is equally grounded: 4.85% net margins remain structurally thin, cash flow is wildly volatile quarter to quarter, and the stock has de-rated with a -43.35% max drawdown and 10.6 points of twelve-month underperformance. On balance the bull evidence currently has the stronger near-term momentum — the Q3 beat and 13% earnings-day gap, the 18.02% one-month gain versus -1.99% for SPY, and zero Sell ratings all point to improving conviction. The single most important tension is whether the 250-300bps of sequential margin improvement is durable contract-driven execution or merely favorable one-time adjustments; if margins hold above 13.5% gross through the next two quarters the forward-PE thesis validates, but a slip back toward the 11.57% Q4 2025 level would collapse the recovery narrative and re-rate the stock lower.
Bullish
- Forward PE of 15.5x prices recovery: The forward PE of 15.48x against a trailing PE of 22.10x implies the market expects roughly 30% EPS growth to $27.80 from the current TTM base, a gap unusually wide for an industrial. If HII delivers on consensus, the stock trades at a meaningful discount to its own trailing multiple and to the high-teens/low-20s sector band.
- Margin expansion is accelerating sequentially: Gross margin rose from 13.17% in Q1 to 13.22% in Q2 to 13.57% in Q3 2026, while operating income climbed from $155 million to $210 million to $246 million over the same span. That is roughly 250-300bps of sequential operating-margin improvement off the 2024 trough, evidence that shipbuilding execution and cost recovery are finally working.
- Revenue growth reaccelerating to 10.8% YoY: Q3 2026 revenue of $3.537 billion grew 10.81% year over year versus $3.192 billion, and the sequential cadence ($3.099B, $3.418B, $3.537B) shows steady expansion. Newport News at $1.910 billion (54% of segment revenue) is the growth engine on Columbia-class ramp and Ford-class follow-on work.
- Analyst consensus buy with 13.1% upside: Twelve analysts split 6 Buy / 6 Hold / 0 Sell with a mean rating of 2.08 and an average target of $358.58, implying 13.1% upside from $316.93. The complete absence of Sell ratings signals the Street debate is about timing and magnitude of upside, not downside risk.
Bearish
- Structurally thin margins versus peers: A 4.85% trailing net margin and 4.87% operating margin are far below the high-single to low-double-digit operating margins typical of defense primes. The 12.70% gross margin structurally justifies part of HII's valuation discount and leaves little cushion if contract adjustments reverse.
- Volatile, working-capital-driven cash flow: Operating cash flow swung from -$390 million in Q1 2026 to -$31 million in Q2 to +$520 million in Q3, with free cash flow ranging from -$464 million to +$429 million. This quarterly whipsaw is a hallmark of shipbuilding and makes the $524 million TTM FCF less reliable than the headline suggests.
- Relative underperformance and deep drawdown: HII is down 0.19% over twelve months versus a 10.39% S&P 500 gain, a 10.6 percentage-point shortfall, and has suffered a -43.35% max drawdown. At $316.93 the stock sits at only 30.1% of its 52-week range ($255.36-$460.00), reflecting a market that has de-rated the name.
- PEG of 2.16 signals no growth-adjusted value: Even after accounting for the expected earnings recovery, the PEG ratio of 2.16 indicates the stock is not statistically cheap on a growth-adjusted basis. The trailing PE of 22.10x sits in the upper-middle of HII's historical 9.41x-25.82x band, so the multiple already embeds optimism.
HII Technical Analysis
HII is in a recovery phase within a broader twelve-month range-bound consolidation, with the stock down 0.19% over the past year versus a 10.39% gain for the S&P 500 — a relative underperformance of roughly 10.6 percentage points. At $316.93, the shares sit at approximately 30.1% of the 52-week range of $255.36 to $460.00, meaning the stock is trading in the lower third of its annual band despite the recent bounce; that positioning reflects a market that has de-rated the name rather than one chasing momentum, and the -43.35% max drawdown underscores how violent the prior decline was. The distance to the 52-week high (~45% above current levels) versus the 52-week low (~19% below) frames an asymmetric setup where the stock has reclaimed meaningful ground off the bottom but remains far from confirming a new uptrend.
Short-term momentum has turned decisively positive and is diverging sharply from the longer-term trend: the stock is up 18.02% over the past month against a -1.99% decline for SPY, a relative strength spread of +20.0 percentage points, while the three-month change remains -24.24%. That divergence is textbook post-capitulation mean reversion — the October 29 earnings release (Q3 EPS of $5.49 and revenue of $3.537 billion, a 10.81% YoY increase) triggered a single-session gap from $279.26 to $316.21, roughly a 13% move on volume that dwarfed the 401,407-share average. The six-month change of +0.70% versus a -2.41% relative strength reading confirms the stock has essentially round-tripped, and the fact that the one-month surge has already retraced the entire three-month decline argues momentum is accelerating but now faces overhead supply from the summer trading range.
Key technical levels are well defined: support sits at the 52-week low of $255.36, with a secondary shelf around the $260-$270 zone where the stock based in late September and early October, while resistance lies at the 52-week high of $460.00 and, more immediately, the $325-$335 area that capped the August rally. A breakout above $335 on sustained volume would confirm a higher-low structure and open a path toward the mid-$300s, whereas a breakdown below $255 would signal the recovery was a failed bounce and likely trigger momentum-driven selling. The reported beta of 0.147 is anomalously low for a defense industrial — it implies roughly 85% less volatility than SPY, which is inconsistent with the observed 43% drawdown and 13% earnings-day gap, so position sizing should rely on realized volatility rather than this figure; the short ratio of 2.82 suggests short interest is moderate and not a major squeeze catalyst.
Beta
0.15
0.15x market volatility
Max Drawdown
-43.4%
Largest decline past year
52-Week Range
$255-$460
Price range past year
Annual Return
-3.8%
Cumulative gain past year
| Period | HII Return | S&P 500 |
|---|---|---|
| 1m | +14.1% | -1.0% |
| 3m | -5.5% | -0.2% |
| 6m | -3.9% | +4.0% |
| 1y | -3.8% | +13.6% |
| ytd | -13.1% | +12.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HII Fundamental Analysis
Revenue is on a clear accelerating trajectory: Q3 2026 revenue of $3.537 billion grew 10.81% year over year versus $3.192 billion in Q3 2025, and the sequential cadence — $3.099 billion in Q1, $3.418 billion in Q2, $3.537 billion in Q3 — shows steady quarter-over-quarter expansion. Segment data for the period shows Newport News Shipbuilding at $1.910 billion, Ingalls at $876 million, and Mission Technologies at $792 million, with the nuclear carrier and submarine yard contributing roughly 54% of segment revenue and clearly the primary growth engine given Columbia-class ramp and Ford-class follow-on work. The consensus revenue estimate of $16.64 billion for the forward year implies continued mid-to-high single-digit growth, and the combination of a 10.81% current YoY rate with a record backlog environment supports the thesis that HII is in the early innings of a multi-year naval procurement upcycle rather than a cyclical peak.
Profitability is improving but remains structurally thin for an industrial: Q3 2026 net income was $217 million on a 6.14% net margin, with gross margin of 13.57% and operating margin of 6.96%, up from 4.57% net margin and 11.57% gross margin in Q4 2025. The margin trajectory across 2026 is unambiguously positive — gross margin rose from 13.17% in Q1 to 13.22% in Q2 to 13.57% in Q3, and operating income climbed from $155 million to $210 million to $246 million over the same span, evidence that shipbuilding execution and cost recovery are finally improving after the 2024 trough when Q4 gross margin was just 10.69%. Still, a 4.85% trailing net margin and 4.87% operating margin are well below typical aerospace and defense levels (prime contractors often run high-single to low-double-digit operating margins), reflecting the fixed-price development risk and heavy labor content inherent to naval shipbuilding; the key question is whether the current 250-300bps of sequential margin expansion is sustainable or reflects favorable contract adjustments.
Balance sheet and cash flow present a mixed picture: debt-to-equity of 0.62 is manageable, the current ratio of 1.13 provides adequate near-term liquidity, and trailing free cash flow of $524 million against a $13.36 billion market cap yields roughly 3.9%. However, the quarterly cash flow pattern is highly volatile — operating cash flow swung from -$390 million in Q1 2026 to -$31 million in Q2 to +$520 million in Q3, and free cash flow ranged from -$464 million to +$429 million over the same quarters — a hallmark of working-capital-intensive shipbuilding where accounts payable and receivables timing dominate. ROE of 11.93% and ROA of 4.57% are modest, and with capital expenditures of $91 million in Q3 alone, the company must sustain the recent cash generation to fund growth internally while covering a dividend with a 1.59% yield and a conservative 35.2% payout ratio.
Quarterly Revenue
$3.5B
2026-09
Revenue YoY Growth
+10.8%
YoY Comparison
Gross Margin
13.6%
Latest Quarter
Free Cash Flow
$524000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HII Overvalued?
Because HII is solidly profitable (Q3 2026 net income of $217 million), the PE ratio is the appropriate primary metric, and the trailing PE of 22.10x against a forward PE of 15.48x implies the market expects roughly 30% earnings growth over the next twelve months — a gap that is unusually wide for an industrial and signals that consensus is pricing a meaningful margin-recovery year. The forward multiple of 15.48x on estimated EPS of $27.80 (versus trailing EPS of roughly $14.34 on a TTM basis) is the crux of the bull case: if HII delivers, the stock is cheap on forward earnings; if execution slips, the trailing multiple looks full for a low-margin shipbuilder. The PEG ratio of 2.16 suggests that even after accounting for growth, the stock is not statistically cheap on a growth-adjusted basis.
Relative to the aerospace and defense sector, HII screens as a discount name on most metrics: the PS ratio of 1.07x and EV/Sales of 1.11x are well below the 2-3x range typical of large-cap defense primes, and the EV/EBITDA of 12.99x is modest versus peers that often trade in the mid-to-high teens. The offset is profitability — a 4.85% net margin and 12.70% gross margin are far below sector norms, which structurally justifies part of the multiple discount; the PB ratio of 2.63x is roughly in line with defense peers. The 1.59% dividend yield is below the sector average, and the 22.10x trailing PE versus a sector that typically trades in the high-teens to low-20s suggests HII is roughly at parity on earnings but at a clear discount on revenue and EBITDA — a valuation that says the market is skeptical of margin durability rather than of the top line.
Historically, HII's own valuation band has been wide: the PE ratio ranged from 9.41x in Q4 2023 to 25.82x in Q3 2024, and the PS ratio ranged from 2.46x in Q4 2024 to 4.82x in Q1 2026. The current trailing PE of 22.10x sits in the upper-middle of that historical range, while the current PS of 1.07x sits at the very bottom — an unusual divergence explained by the earnings base having compressed faster than revenue. That combination suggests the market is pricing in optimistic earnings recovery (high PE on depressed earnings) while assigning minimal value to the revenue stream, a setup that historically resolves favorably when margins normalize but leaves little cushion if the recovery stalls.
PE
22.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~26x
vs. Industry Avg
39.4x
Industry PE ~39.4x*
EV/EBITDA
13.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin fragility and cash-flow volatility. A 4.85% trailing net margin and 12.70% gross margin leave HII with minimal buffer against fixed-price development overruns, and the 2024 trough of 10.69% gross margin shows how quickly profitability can compress. Quarterly operating cash flow swung from -$390 million in Q1 2026 to +$520 million in Q3, with free cash flow ranging from -$464 million to +$429 million, meaning the $524 million TTM FCF is heavily dependent on working-capital timing rather than steady conversion. Revenue is also concentrated: Newport News at $1.910 billion represents roughly 54% of segment revenue, so any disruption to carrier or submarine programs would hit the majority of the top line, and debt-to-equity of 0.62 plus a current ratio of only 1.13 leaves limited liquidity headroom if a program slips.
Market and competitive risks stem from valuation sensitivity and an evolving competitive landscape. The trailing PE of 22.10x sits in the upper-middle of HII's historical 9.41x-25.82x band while the PS of 1.07x sits at the very bottom of its 2.46x-4.82x range — an unusual divergence that offers little cushion if the earnings recovery stalls, and the PEG of 2.16 confirms no growth-adjusted discount. The reported beta of 0.147 is anomalously low and inconsistent with the observed -43.35% max drawdown and 13% earnings-day gap, so true market sensitivity is materially higher than the figure implies. Competitively, Anduril's $2.9 billion contract and submarine-component entry plus Saronic's robotic-warship funding introduce venture-backed disruption to a historically duopolistic market, while the stock's -20.0% YTD relative strength versus SPY signals it is out of favor with momentum allocators.
In a worst-case scenario, a margin-recovery stall would compound across several fronts: gross margin reverting toward the 11.57% Q4 2025 level, a fixed-price program charge at Newport News, and a broader defense-sector rotation would likely drive the stock back toward its 52-week low of $255.36, roughly -19% from the current $316.93. The analyst low target of $281.00 sits about -11% below the current price and already prices in margin compression or execution setbacks, while the -43.35% historical max drawdown demonstrates the tail risk if a full de-rating occurs alongside an earnings miss. A realistic adverse path is a retest of the $255-$270 support shelf, translating to a loss of roughly 15-19% from current levels, with a more severe -35% to -40% outcome only if the naval procurement narrative itself weakens.
FAQ
The most severe risk is margin fragility: a 4.85% trailing net margin and 12.70% gross margin leave almost no buffer, and the Q4 2025 gross margin of 11.57% versus Q3 2026's 13.57% shows how quickly profitability can swing on fixed-price contract adjustments. Second is cash-flow volatility — operating cash flow ranged from -$390 million in Q1 2026 to +$520 million in Q3, and free cash flow from -$464 million to +$429 million, so the $524 million TTM figure is working-capital dependent rather than steady. Third is competitive disruption: Anduril's $2.9 billion contract and submarine-component entry plus Saronic's venture-funded robotic warship push threaten long-term pricing in what has been a duopoly. Fourth is valuation and momentum risk — the stock is down 0.19% over twelve months versus a 10.39% S&P gain, has suffered a -43.35% max drawdown, and its reported beta of 0.147 understates true sensitivity given the 13% earnings-day gap, meaning position sizing should rely on realized rather than reported volatility.
The base case carries 50% probability and targets $340-$375, anchored on the $358.58 average analyst target, assuming EPS of roughly $27.80 on $16.64 billion revenue with gross margin holding in the 13.0-13.5% band. The bull case at 30% probability targets $380-$406, requiring gross margin sustained above 13.5%, operating margin pushing toward 8%, and multiple expansion toward the upper end of HII's historical PE band on the back of a 355-ship Navy and $1.5 trillion Pentagon budget. The bear case at 20% probability targets $255-$281, the zone between the 52-week low and the analyst low target, triggered by margin reversion toward 11.57%, a fixed-price program charge at Newport News, or defense-sector rotation. The base case is most likely because three quarters of sequential margin improvement are already in the data, but the key assumption — no new program charge — is binary in nature, which is why the target range is so wide ($281 to $406).
The answer depends on which multiple you weight, and that divergence is the heart of the debate. On trailing earnings HII looks full at 22.10x, in the upper-middle of its own 9.41x-25.82x historical band, and the PEG of 2.16 confirms no growth-adjusted bargain. On forward earnings it looks cheap at 15.48x, and on revenue it looks deeply discounted — PS of 1.07x and EV/Sales of 1.11x sit at the very bottom of HII's 2.46x-4.82x historical range and well below the 2-3x typical of large-cap defense primes, with EV/EBITDA of 12.99x also modest versus peers in the mid-to-high teens. That combination — high PE on depressed earnings but minimal value assigned to revenue — implies the market is skeptical of margin durability rather than of the top line. If gross margin normalizes toward 13.5%+, the stock is undervalued; if it reverts toward 11.57%, the trailing multiple is deserved and the stock is fairly to slightly overvalued.
From a risk/reward standpoint HII is a reasonable but not compelling buy at $316.93: the average analyst target of $358.58 implies 13.1% upside, and the forward PE of 15.48x on consensus EPS of $27.80 is genuinely cheap if the margin recovery holds. The downside is well mapped — the analyst low target of $281 sits about 11% below the current price and the 52-week low of $255.36 about 19% below — so the reward-to-risk is roughly 1:1 to 1.5:1, not the asymmetry value investors prefer. The stock has already rallied 18.02% in a month versus -1.99% for SPY, meaning much of the post-earnings re-rating is captured, and the 6 Buy / 6 Hold split with zero Sells shows the Street itself is undecided. It is a good buy for patient investors willing to accumulate on pullbacks toward the $280-$290 zone, and a poor buy for anyone chasing the recent momentum without tolerance for another 15-20% drawdown.
HII fits a long-term holding profile far better than a short-term trading one. The business is a multi-year naval procurement story — Columbia-class submarines, Ford-class carriers, and a proposed 355-ship fleet — where revenue visibility extends years out, but earnings are lumpy and the stock's -43.35% max drawdown and 13% single-day earnings gap make short-term positioning a bet on quarterly contract adjustments rather than on the franchise. The 1.59% dividend yield with a conservative 35.2% payout ratio rewards patience modestly, and the 10.81% revenue growth with a forward PE of 15.48x suggests the payoff comes from multiple normalization over several years, not from a near-term catalyst. A reasonable minimum holding period is 18-24 months, long enough to see whether the margin recovery is structural and to capture at least one full appropriations cycle; traders should note the short ratio of 2.82 offers no meaningful squeeze dynamic to exploit.

